We chose intranasal administration of UCT-MSC-EXs as we felt it delivered better efficacy than intravenous administration for crossing the BBB
Semaglutide and tirzepatide are approved medicines with years of post-marketing surveillance behind them
Standard beginner protocols typically involve 1-2 mg administered subcutaneously 2-3 times per week, with most researchers running 8-12 week cycles followed by 4-6 week breaks
Advanced protocol Experienced researchers sometimes use higher doses, though diminishing returns and increased side effect risk apply
For hair thinning Hair loss on GLP-1 medications is often related to rapid weight loss and protein deficiency
Anti wrinkle injections are not appropriate during pregnancy or breastfeeding, in patients with neuromuscular conditions (myasthenia gravis, Lambert-Eaton syndrome, motor neurone disease), patients on aminoglycoside antibiotics, those with active infection at the injection site, or those with known hypersensitivity to botulinum toxin
